Search for a rare disease
Other search option(s)
Steinert myotonic dystrophy
Steinert disease, also known as myotonic dystrophy type 1, is a muscle disease characterized by myotonia and by multiorgan damage that combines various degrees of muscle weakness, arrhythmia and/or cardiac conduction disorders, cataract, endocrine damage, sleep disorders and baldness.
ORPHA:273Classification level: Disorder
It is the most frequent of the adult-onset muscular dystrophies; its prevalence is estimated at 1/20,000 inhabitants.
The disease is associated with abnormalities at the 19q13-2 locus (abnormally high CTG triplet repetition).
Detection of the 19q13-2 anomalies using molecular genetic techniques confirms the diagnosis.
Prenatal diagnosis is proposed especially for maternal transmission because of the severity of the possible neonatal forms.
Transmission is autosomal dominant, and anticipation may occur, that is, disease may be more severe and occur earlier in offspring. Genetic counseling is often delicate for this condition because of the wide variability in clinical expression, both within and between families.
Management and treatment
Management ideally includes multidisciplinary annual follow-up.
Disease course is usually slowly progressive but rapid deterioration may sometimes be observed. Life expectancy is reduced by the increased mortality associated with the pulmonary and cardiac complications.
Article for general public
- Emergency guidelines
- Español (2014, pdf)
- Deutsch (2010, pdf)
- Polski (2010, pdf)
- Italiano (2010, pdf)
- English (2010, pdf)
- Français (2010, pdf)
- Review article
- Français (2007, pdf)
- Guidance for genetic testing
- Français (2016, pdf)
- Clinical genetics review
- English (2019)